LAB
Standard BioTools Inc. Healthcare Medical Devices
9/12
Innovation Score
Patent Activity
2/3
10 patents found
FUZZY
Cash Runway
3/3
60 months of cash remaining based on current burn rate.
Cash on hand: $455.2M
Cash on hand: $455.2M
Revenue Trajectory
1/3
Revenue: $86.3M
YoY Growth: +4.6%
YoY Growth: +4.6%
Management Quality
3/3
Insider ownership: 46.1%
SBC/Revenue: 0.0%
No reverse splits detected
SBC/Revenue: 0.0%
No reverse splits detected
Key Metrics
Market Cap
$402.1M
Revenue
$86.3M
Revenue Growth (YoY)
+4.6%
Cash on Hand
$455.2M
Cash Runway
60 months
Shares Outstanding
390.4M
Insider Ownership
46.1%
SBC / Revenue
0.0%
Sector / Industry
Healthcare / Medical Devices
Patents (10)
Match type: FUZZY — company name matched partially; verify assignee
- High resolution imaging apparatus and method
- Reagents and methods for elemental mass spectrometry of biological samples
- Inductively coupled plasma based atomic analysis systems and methods
- Polymer backbone element tags
- Autofocus sample imaging apparatus and method
7-Step Risk Assessment
How LAB maps to our micro cap methodology:
- Innovation Signal 10 patents identified. This suggests the company is investing in defensible IP.
- Cash Runway Check 60 months of runway. Comfortable buffer for execution.
- Revenue Trajectory +4.6% YoY growth on $86.3M revenue. Positive but moderate growth.
- Management Alignment Insiders hold 46.1% of shares. SBC is 0.0% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $402.1M company.
Financial Detail
Free Cash Flow
$-13.4M
FCF Yield
-3.3%
Return on Equity
-9.9%
Debt / Equity
5.3%
Gross Margin
53.3%
Profit Margin
90.7%
Operating Margin
-44.5%
Price / Book
0.72
Current Ratio
12.36
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Quality Flags
Low Debt
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-05-23